Heart Metabolics

Heart Metabolics

United States
Heart Metabolics Limited is pioneering a pharmaceutical therapy for the treatment of hypertrophic cardiomyopathy (“HCM”). HCM is a condition in which the heart muscle becomes thick. The thickening makes it harder for blood to leave the heart forcing the heart to work harder to pump blood, leading in many cases to heart failure. Sudden death is caused frequently. There are over 100,000 cases of HCM in the United States alone, often presenting more severely in young adults and athletes; unfortunately the younger the individual is when diagnosed with HCM, the more likely that the individual has a severe form. Although various cardiovascular drugs are currently used to treat HCM, there are patients who are not being helped by current therapeutics. In response to this medical need and based on encouraging phase II clinical trial results to date, Heart Metabolics is developing perhexiline as a therapeutic for all types of HCM. Perhexiline is currently an approved drug in Australia and New Zealand for the treatment of angina. Heart Metabolics plans to conduct clinical trials in the U.S. and seek FDA approval of perhexiline as an orphan drug; the company currently has such an orphan designation from the FDA.
Founded date
01/10/2012
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$10M to $50M
# of funders
1
Founders
Houman Ashrafian
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
Brandon Capital Partners, Seroba Life Sciences, EQT life science, venBio Partners, AshHill Biomedical
# of funding runds
2
Last founding
$20.000.000
Total funded
$24.000.000

See more companies

See full list
Amethyst Radiotherapy

Amethyst Radiotherapy

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Refocus Group

Refocus Group

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ZyVersa Therapeutics

ZyVersa Therapeutics

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
AbilTo

AbilTo

Estimated revenue
$1M to $10M
# of employees
101-250
Company type
For Profit
Axio Biosolutions

Axio Biosolutions

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Health Hero Network

Health Hero Network

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
REACH Health

REACH Health

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.